Patents by Inventor Michael Diegel

Michael Diegel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150344543
    Abstract: Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions that comprise ARF polypeptides. ARF polypeptides and ARF polypeptide-based compositions are useful in the treatment of cancer and infectious disease.
    Type: Application
    Filed: May 29, 2015
    Publication date: December 3, 2015
    Inventors: THOMAS GRADDIS, REINER LAUS, MICHAEL DIEGEL, DAMIR VIDOVIC
  • Patent number: 9051385
    Abstract: Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions that comprise ARF polypeptides. ARF polypeptides and ARF polypeptide-based compositions are useful in the treatment of cancer and infectious disease.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: June 9, 2015
    Assignee: DENDREON CORPORATION
    Inventors: Thomas Graddis, Reiner Laus, Michael Diegel, Damir Vidovic
  • Publication number: 20100034842
    Abstract: Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions that comprise ARF polypeptides. ARF polypeptides and ARF polypeptide-based compositions are useful in the treatment of cancer and infectious disease.
    Type: Application
    Filed: October 5, 2009
    Publication date: February 11, 2010
    Inventors: Thomas Graddis, Reiner Laus, Michael Diegel, Damir Vidovic
  • Patent number: 7597894
    Abstract: Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions and methods that employ alternative reading frame polypeptides. ARF polypeptides and ARF polypeptide-based compositions and methods are useful in the treatment of cancer and infectious disease.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: October 6, 2009
    Assignee: Dendreon Corporation
    Inventors: Thomas Graddis, Reiner Laus, Michael Diegel, Damir Vidovic
  • Publication number: 20050112134
    Abstract: Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions and methods that employ alternative reading frame polypeptides. ARF polypeptides and ARF polypeptide-based compositions and methods are useful in the treatment of cancer and infectious disease.
    Type: Application
    Filed: March 5, 2004
    Publication date: May 26, 2005
    Applicant: DENDREON CORPORATION
    Inventors: Thomas Graddis, Reiner Laus, Michael Diegel, Damir Vidovic